Eton Pharmaceuticals (ETON) Invested Capital (2019 - 2025)
Historic Invested Capital for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $25.9 million.
- Eton Pharmaceuticals' Invested Capital rose 2882.72% to $25.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.9 million, marking a year-over-year increase of 2882.72%. This contributed to the annual value of $54.2 million for FY2024, which is 25044.91% up from last year.
- Eton Pharmaceuticals' Invested Capital amounted to $25.9 million in Q3 2025, which was up 2882.72% from $26.7 million recorded in Q2 2025.
- Eton Pharmaceuticals' Invested Capital's 5-year high stood at $54.4 million during Q1 2025, with a 5-year trough of $15.5 million in Q4 2023.
- Its 5-year average for Invested Capital is $24.7 million, with a median of $21.1 million in 2023.
- Per our database at Business Quant, Eton Pharmaceuticals' Invested Capital tumbled by 2996.67% in 2022 and then skyrocketed by 25044.91% in 2024.
- Eton Pharmaceuticals' Invested Capital (Quarter) stood at $22.9 million in 2021, then dropped by 19.35% to $18.5 million in 2022, then dropped by 16.17% to $15.5 million in 2023, then skyrocketed by 250.45% to $54.2 million in 2024, then tumbled by 52.24% to $25.9 million in 2025.
- Its last three reported values are $25.9 million in Q3 2025, $26.7 million for Q2 2025, and $54.4 million during Q1 2025.